Use access key #2 to skip to page content.
$0.97 -0.13 (-11.82%)
10/10/2008 2:23 PM

GPC Biotech AG (ADR) (GPCB)

CAPS Rating:
*

The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.

View All Commentary (GPCB)

Recs

0

Avatar lavongduhr (< 20) Submitted: 5/30/08 9:41 AM : Outperform Start Price: $4.10 GPCB Score: -39.43

biopharmaceutical company that researches and develops anitcancer drugs. currently in phase I trial for satraplatin, which is a radiation drug that is a therapeutic for non-small lung cancer patients

Report this Post Replies: 0 | Reply

Featured Broker Partners